Cargando…
Bile Acids: Key Players in Inflammatory Bowel Diseases?
Inflammatory bowel diseases (IBDs) have emerged as a public health problem worldwide with a limited number of efficient therapeutic options despite advances in medical therapy. Although changes in the gut microbiota composition are recognized as key drivers of dysregulated intestinal immunity, alter...
Autores principales: | Kriaa, Aicha, Mariaule, Vincent, Jablaoui, Amin, Rhimi, Soufien, Mkaouar, Hela, Hernandez, Juan, Korkmaz, Brice, Lesner, Adam, Maguin, Emmanuelle, Aghdassi, Ali, Rhimi, Moez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909766/ https://www.ncbi.nlm.nih.gov/pubmed/35269523 http://dx.doi.org/10.3390/cells11050901 |
Ejemplares similares
-
Gut Serpinome: Emerging Evidence in IBD
por: Mkaouar, Héla, et al.
Publicado: (2021) -
Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health
por: Bourgin, Mélanie, et al.
Publicado: (2021) -
SP-1, a Serine Protease from the Gut Microbiota, Influences Colitis and Drives Intestinal Dysbiosis in Mice
por: Kriaa, Aicha, et al.
Publicado: (2021) -
The Nexus of Diet, Gut Microbiota and Inflammatory Bowel Diseases in Dogs
por: Rhimi, Soufien, et al.
Publicado: (2022) -
Microbial impact on cholesterol and bile acid metabolism: current status and future prospects
por: Kriaa, Aicha, et al.
Publicado: (2019)